ContentslistsavailableatScienceDirect
Vaccine
jo u rn al h om ep a g e :w w w . e l s e v i e r . c o m / l o c a t e / v a c c i n e
Peptide-specific
T
helper
cells
identified
by
MHC
class
II
tetramers
differentiate
into
several
subtypes
upon
immunization
with
CAF01
adjuvanted
H56
tuberculosis
vaccine
formulation
Gennaro
Prota
a,
Dennis
Christensen
b,
Peter
Andersen
b,
Donata
Medaglini
a,
Annalisa
Ciabattini
a,∗aLaboratoriodiMicrobiologiaMolecolareeBiotecnologia(LA.M.M.B.),DipartimentodiBiotecnologieMediche,UniversitàdiSiena,Siena,Italy bDepartmentofInfectiousDiseaseImmunology,StatensSerumInstitut,Copenhagen,Denmark
a
r
t
i
c
l
e
i
n
f
o
Articlehistory:
Received20February2015 Receivedinrevisedform17July2015 Accepted9September2015 Availableonline20October2015 Keywords: CD4+Tcellpriming MHCclassIItetramers Thelpersubsets Subcutaneousimmunization
a
b
s
t
r
a
c
t
CD4+T-cellprimingisanessentialstepinvaccinationduetothekeyroleofThelpercellsindriving
botheffectorandmemoryimmuneresponses.HerewehavecharacterizedinC57BL/6micetheThelper
subtypedifferentiationamongtetramer-specificCD4+Tcellsprimedbysubcutaneousimmunizationwith
thetuberculosisvaccineantigenH56plustheadjuvantCAF01.Peptide-specificpopulationidentified
bytheMHCclassIItetramersdifferentiatedintoseveralThelpersubtypesuponantigenencounter,
andthefrequencyofsubpopulationsdifferedaccordingtotheirlocalization.Th1(CXCR3+T-bet+),Tfh
(CXCR5+PD-1+Bcl-6+)andROR␥t+cellswereinducedinthelymphnodesdrainingtheimmunization
site(dLN),whileTh1cellswerethepredominantsubtypeinthespleen.Inaddition,CD4+Tcells
co-expressingmultipleT-celllineage-specifyingtranscriptionfactorswerealsodetected.Inthelungs,most
ofthetetramer-bindingTcellswereROR␥t+,whileTfhandTh1cellswereabsent.Afterboosting,ahigher
frequencyoftetramer-bindingcellsco-expressingthemarkersCD44andCD127wasdetectedcompared
toprimedcells,andcellsshowedaprevalentTh1phenotypeinbothdLNandspleens,whileTfhcellswere
significantlyreduced.Inconclusion,thesedatademonstratethatparenteralimmunizationwithH56and
CAF01elicitsadistributionofantigen-specificCD4+Tcellsinbothlymphoidtissuesandlungs,andgives
risetomultipleThelpersubtypes,thatdifferdependingonlocalizationandfollowingreactivation.
©2015TheAuthors.PublishedbyElsevierLtd.ThisisanopenaccessarticleundertheCCBY-NC-ND
license(http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Thelpercellsplayafundamentalroleintheadaptiveimmune responseuponvaccination,sincetheyarerequiredforthe induc-tion of effector as well as memory immune responses [1–3]. CharacterizationofT-cellpriminginducedbyavaccinationstrategy iscriticalinordertodevelopoptimalprime-boostcombinations capableofelicitingthetypeofimmuneresponserequiredtofight aspecificpathogen[4].Magnitude,qualityandlocalizationof pri-maryThelper(Th)cellresponsesareoffundamentalimportance fortheevaluationofnovelvaccinecandidates.T-cellprimingcan beevaluatedasatargetforimprovingandmodulatingtheimmune responseduringvaccination[5],andasanearlypredictorofvaccine
∗ Correspondingauthorat:Università diSiena,Dipartimentodi Biotecnolo-gieMediche,LaboratoriodiMicrobiologiaMolecolareeBiotecnologia(LA.M.M.B.), PoliclinicoLeScotte,Vlottopiano1,VialeBracci,Siena53100,Italy.
Tel.:+390577233100;fax:+390577233334.
E-mailaddress:annalisa.ciabattini@unisi.it(A.Ciabattini).
immunogenicity[6,7]. CD4+ T-cell priminghasbeenstudied to characterizethemechanismofactionofabroadrangeofadjuvants suchasalum[8],CpGODN[9],lipopolysaccharide[10],cholera toxin[11]oritsBsubunit(CTB)[12].
TheanalysisofThelpercellsubsetsallowsthecharacterization ofthespecializedeffectorcellselicitedbyvaccination.Upon anti-genencounter,clonallyexpandedCD4+ Tcells differentiateinto variousfunctionallydefinedeffectorsubpopulations,accordingto thelocalpro-inflammatoryenvironment,thedoseandtheroute ofthevaccineused[13–15]. BesidestheTh1,Th2,Th17and T-regsubtypes,Tfollicularhelper(Tfh)cellshaveemergedinrecent yearsasanotherCD4+Tcellsubtypeessentialforpromotingthe differentiationofactivatedBcellsintomemoryBcellsandlong livedplasma-cells[16].The inductionofTfhcellsis thereforea target for vaccines aimedat stimulatinga protective antibody-mediated immune response. Tfh cells express many molecules importantfortheirdifferentiationandfunction,suchasthe fol-liclehomingchemokinereceptorCXCR5,thetranscriptionalfactor B-celllymphoma-6 (Bcl6), theprogrammedcell death-1(PD-1) [17].
http://dx.doi.org/10.1016/j.vaccine.2015.09.024
0264-410X/©2015TheAuthors.PublishedbyElsevierLtd.ThisisanopenaccessarticleundertheCCBY-NC-NDlicense(http://creativecommons.org/licenses/by-nc-nd/ 4.0/).
6824 G.Protaetal./Vaccine33(2015)6823–6830 TheexvivostudyofprimedCD4+Tcellsistechnicallylimited
duetotheverylowfrequencyofantigen-specificTcells. Antigen-specificTcellresponseshavebeendetectedbyfunctionalassays uponinvitroantigenicrestimulation.Nevertheless,since pheno-typicandfunctionalpropertiesofreactivatedcellsmaybealtered bythisrestimulationphase[18],technologiessuchastheadoptive transferofTCR-transgenicTcellsinrecipientmice[9,12,19–22,22] and,morerecently,MHCclassIItetramers[23]havebeen devel-opedandemployedtostudyT-cellpriminguponvaccination[2]. MHCclassII-peptidecomplextetramersinparticular,have pro-videdan invaluableway ofmonitoring exvivo T-cell mediated immuneresponsesandquantifyingthedevelopmentofan antigen-dependentresponseinanimalstudies[23–26].
In the present study we have identified and characterized, by using the tetramer technology, CD4+ T cells specific for a peptideof the Mycobacteriumtuberculosis vaccine antigen H56 uponparenteralimmunization.H56isapromisingvaccine candi-dateconsistingof6-kDaearlysecretoryantigenictarget(ESAT-6), Ag85B,andtheproteinRv2660,thatisacomponentofvaccines currentlyin clinicaltrials (ClinicalTrials.govIdentifier numbers: NCT01967134,NCT01865487)[27].Thesolubleantigenwashere combinedwiththeadjuvantCAF01,a liposomesystemthathas beenshown toinduce combined Th1 and Th17 responses and promoterobustlong-livedmemoryimmunity[28–30];CAF01has recentlybeenalsotestedinhumanstudies[31].Themagnitudeand qualityofthepeptide-specificCD4+Tcellresponseelicitedby sub-cutaneous(SC)immunizationwithH56andCAF01wasassessed byemployingMHCclassIItetramerscomplexedwithan Ag85B-derivedpeptide,intheC57BL/6mousemodel.Theexpansionof Ag85B-tetramerbindingcells,theirsubtypedifferentiationand dis-seminationtowardseffectorsiteswereanalyseduponprimingand subsequentboosting.
2. Materialsandmethods 2.1. Mice
Eight-weeksoldfemaleC57BL/6mice,purchasedfromCharles River(Lecco,Italy)weremaintainedunderspecificpathogen-free conditions at theUniversity of Siena, and treated according to nationalguidelines(DecretoLegislativo26/2014).Allanimal stud-ieswereapprovedbytheEthicsCommittee“ComitatoEticoLocale dell’AziendaOspedalieraUniversitariaSenese”andtheItalian Min-istryofHealth(number4/2011,ondate20/07/2011).
2.2. Immunizationsandsamplecollection
MicewereimmunizedbytheSCroutewiththeM.tuberculosis fusionproteinH56[27](10g/mouse)mixedwiththeadjuvant CAF01 [30] (250g dimethyldioctadecylammonium (DDA) and 50gtrehalosedibehenate(TDB)/mouse;StatensSerumInstitut, Denmark).SCimmunizationwasperformedatthebaseofthetail inatotalvolumeof150lofTRISHCl10M.Groupsofmicewere immunizedatday0andsacrificedonday7,orboostedatweek 4,andsacrificed7dayslater.Iliac(subiliac,medialandexternal) lymphnodes,lungsandspleenswerecollected7daysafter pri-maryorboosterimmunizationandtreatedaspreviouslydescribed [20].
2.3. Flowcytometricanalysis
Cells were incubated for 30min at 4◦C in Fc-blocking solution (complete medium plus 5g/ml of CD16/CD32 mAb [clone 93; eBioscience, CA, USA]) and then stained for 1h at RT with PE-conjugated I-A(b) M. tuberculosis Ag85B precur-sor 280–294 (FQDAYNAAGGHNAVF), or PE-conjugates human
classII-associatedinvariantchainpeptide(PVSKMRMARPLLMQA) tetramers(kindlyprovidedby NIHMHC TetramerCoreFacility, EmoryUniversity,Atlanta,GA)togetherwithAPC-conjugated anti-CXCR5(clone2G8,BDbiosciences,CA,USA).Surfacestainingwas performedonicewithFITC-conjugatedanti-PD-1(cloneJ43), PE-CY7-conjugatedanti-CXCR3(cloneCXCR3-73,bothfromBiolegend, CA, USA), HV500-conjugated anti-CD4 (clone RM4-5), HV450-conjugatedanti-CD44(cloneIM7,bothfromBDbiosciences)and PerCp-eFl710-conjugatedanti-CD127(cloneSB/199,eBioscience). SampleswerelabelledwithLIVE/DEADFixableNearIRDeadCell Stain Kit according to the manufacturer’sinstructions (Invitro-gen,USA).IntracellularstainingforBV605-conjugatedanti-T-bet (clone 4b10, Biolegend), PECF594-conjugated anti-Bcl-6 (clone K112-91)andPerCPCY5.5-conjugatedanti-ROR␥t(cloneQ31-378, bothfromBDbiosciences)wasperformedusingtheFoxp3staining bufferset (eBioscience)according tothe manufacturer instruc-tion.Antibodiesandtetramersweretitratedforoptimaldilution. CD44+ tetramer+ cells were identified using a gating strategy basedonlivecells,FSC×SSClymphocytecharacteristics,singlets and CD4+ expression; gateswere setaccordingtoFluorescence MinusOne(FMO)controls.About106 cellswerestoredforeach sampleacquiredonLSRIIflowcytometer(BDbiosciences);data analysis was performed using FlowJo software (TreeStar, OR, USA).
2.4. Cytokineassay
IFN-␥,IL-4,IL-10,IL-17A,IL-2andIL-21productionwasassessed inculturesupernatantsofrestimulatediliaclymphnodescellsby Bio-Plexcytokineimmunoassay(Bio-Rad).Lymphocyteswere cul-turedwith5g/mlofH56incompletemediumfor72hat37◦Cin 5%CO2.IFN-␥,IL-4,IL-10,IL-17A,IL-2cytokinesweredetectedin supernatantsusingthe5-plexassaysystem,whileIL-21was ana-lysedindividually.Cytokinedetectionwasperformedfollowingthe manufacturer’sprotocol,andanalysedbyLuminex100(Bio-Rad). Cytokineconcentrationswerecalculatedbasedonstandardcurve datausingBio-PlexManagersoftware(version4.0).
2.5. Statisticalanalysis
Two-tailedStudent’st-testwasemployedtoanalysestatistical differencesbetweenthefrequenciesofAg85B-specificCD4+Tcells detectedinprimedandboostedgroups,andbetweenthe percent-ageofT-helpersubsetsdetectedinprimedand boostedgroups. StatisticalsignificancewasdefinedasP≤0.05.Graphpad4.0 soft-warewasusedforanalysis.
3. Results
3.1. PrimedAg85B-specificCD4+Tcellsdifferentiateintomultiple Thsubtypesaccordingtotheirlocalization.
Theprimaryantigen-specificCD4+T-cellresponsewasstudied afterSCimmunizationwithH56plusCAF01adjuvant inlymph nodesdraining theimmunizationsite (dLN),spleenand alsoin thelungs,thatareanessentialeffectorsite forfightingairways pathogens.CD4+Tcellsspecificfortheimmunodominantepitope ofAg85B,thatispartoftheH56fusion protein,wereidentified usingAg85B280–294-complexed MHC classII tetramers.Staining specificityofAg85B280–294-complexedMHCclassIItetramerswas determined usinga controltetramer complexedwith an unre-latedantigenthatshowedalevelofstainingbelow0.02% (data notshown).Tetramer-positive(Tet+)Tcellsubtypeswere charac-terized7daysafterprimingfortheexpressionofsurfacemarkers and transcription factorsindicative of Tfh,Th1, and Th17 sub-typedifferentiation.Tfhcellphenotypewasidentifiedbyassessing
Fig.1.CharacterizationofAg85B-specificCD4+Tcellsubpopulationsinlymphnodesdrainingtheimmunizationsite.C57BL/6micewereprimedwithH56andCAF01bythe
SCroute,andsacrificed7dayslater.LymphocytesfromdLNwerecollected,stainedwithAg85B280–294MHCclassIItetramer,andanalysedfortheexpressionofsurfacemarkers
andintracellulartranscriptionfactorsforidentifyingdifferentsubpopulations.(A)DetectionofTet+TcellsasCD44highTet-Ag85B+cellsgatedonliveCD4+lymphocytes
(a);percentageofTet+TcellsrespecttoCD4+Tcellsisreported.GatedTet+TcellswereassessedfortheexpressionofCXCR5andPD-1cells(b),anddouble-positivecells
(indicatedasTfh,withfrequencyrespecttoTet+Tcells)wereanalysedforBcl-6expression(c,filledhistogram;inoveralyBcl-6expressionassessedinCD4+CD44−tetramer−
cells,openhistogram).BothTfhandnon-TfhcellswereassessedfortheexpressionofCXCR3(dande,percentagesreportedarereferredtoTfhandnon-Tfhcellsrespectively), andnon-TfhCXCR3+cellswereanalysedfortheexpressionofT-bet(f,filledhistogram,inoverlayitsexpressionassessedinCD4+CD44−tetramer−cells,openhistogram).
Tet+TcellsweretestedforROR␥texpression(g,percentagereportedisreferredtoTet+Tcells),andgatedpositivecellswereanalysedfortheexpressionofBcl-6versus
T-bet(h,percentagesreportedineachquadrantarereferredtoROR␥t+cells).(B)ROR␥t(green),Bcl-6(orange),andT-bet(blue)expressionacrossCXCR5versusPD-1dot
plotanalysis.Dotplotsrepresentasingleanimalfrom2independentexperimentswith5miceeach;about106cellswerestoredforeachsample.
theexpressionofPD-1andCXCR5togetherwiththeintracellular expressionofBcl-6[33],Th1cellsweredetectedbytheexpression ofCXCR3andT-bet[34],whileTh17byROR␥t[35].Antigen-specific CD4+TcellswerenotdetectedusingMHCclassIItetramers spe-cificfortheESAT6peptide(QQWNFAGIEAAASA,datanotshown), furtherconfirmingtheimmunodominanceoftheselectedAg85B epitope,asshownalsoinpreviousstudies[32].
3.2. ThelpersubpopulationsindLN
IndLNTet+Tcellsexpanded(0.32%oftotalCD4+Tcells)and differentiatedintoseveralThelpercellsubpopulations(Fig.1A). About20%ofTet+TcellsexpressedtheTfhsurfacemarkers PD-1andCXCR5(Fig.1A,panelb)andthesegatedcellsexpressedat highlevelsthespecificBcl-6transcriptionfactor(Fig.1A,panelc). About40%ofgatedTfhcellsexpressedCXCR3,amarker preferen-tiallymaintainedbycellscommittedtotheTh1cellpathway[36]
(Fig.1A,paneld),buttheydidnotexpresstheTh1master regula-torfactorT-bet(datanotshown).Ithasbeenpreviouslyreported thatcirculatingCD4+CXCR5+TcellscanexpressCXCR3[37],here weshowthatalsolymphnoderesidentTfhcellscanexpressthis chemokinereceptor.Amongnon-Tfhgatedcells(Fig.1A,panelb) 60%expressedCXCR3(Fig.1A,panele),andmostofthemwere T-bet-positive(Fig.1A,panelf)indicatingthedifferentiationintoTh1 cells.CXCR3+T-bet+Th1cellsthusmadeupabout27%oftheTet+T cells.
About 40% of Tet+ Tcells expressedthe Th17 master regu-latorfactor ROR␥t(Fig.1A,panelg), andinterestingly,manyof gatedROR␥t+ cells co-expressedothermasterregulatorfactors, suchas Bcl-6(22%) or T-bet (21%),while about55% were pos-itive onlyfor ROR␥t(Fig.1A, panelh). Thisanalysisshows the presenceof“transitional”phenotypesinwhichtheco-expression ofmore thanone “master”transcription factorcanbedue toa transientstatusofcellsthatwereredirectingtheirphenotypeand
6826 G.Protaetal./Vaccine33(2015)6823–6830
Fig.2. CharacterizationofAg85B-specificCD4+Tcellsubpopulationsinspleenandlungs.C57BL/6micewereprimedwithH56andCAF01bytheSCroute,andsacrificed
7dayslater.LymphocytesfromSPL(A)andlungs(B)werecollected,stainedwithAg85B280–294MHCclassIItetramer,andanalysedfortheexpressionofsurfacemarkers
andintracellulartranscriptionfactorsforidentifyingdifferentsubpopulations.(A)DetectionofTet+TcellsasCD44highTet-Ag85B+cellsgatedonliveCD4+lymphocytes(a);
percentageofTet+TcellsrespecttoCD4+Tcellsisreported.GatedTet+TcellswereassessedfortheexpressionofCXCR5andPD-1(b)anddouble-positivecells(indicatedas
Tfh,withfrequencyrespecttoTet+Tcellsinbrackets)wereanalysedforBcl-6expression(c,filledhistogram;inoverlayBcl-6expressionassessedinCD4+CD44−tetramer−
cells,openhistogram).Non-TfhcellswereanalysedfortheexpressionofCXCR3(paneld,percentagereportedisreferredtonon-Tfhcells),andgatedCXCR3+cellswere
analysedfortheexpressionofT-bet(e,filledhistogram,inoverlayitsexpressionassessedinCD4+CD44−tetramer−cells,openhistogram).Tet+TcellsweretestedforROR␥t
expression(f,percentagereportedisreferredtoTet+Tcells),andgatedpositivecellswereanalysedfortheexpressionofBcl-6versusT-bet(g,percentagesreportedineach
quadrantarereferredtoROR␥t+cells).(B)Sameanalysisdescribedin(A),performedinthelungs.Percentagesofpositivecellsarereportedineachdotplot.Dotplotsshown
representasingleanimalfrom2independentexperimentswith5miceeach;about106cellswerestoredforeachsample.
functiontowardsonespecificsubtype.CellsexpressingROR␥twere equallydistributedbetweenCXCR5andPD-1positiveornegative subpopulations,whileBcl-6andT-betshowedaclearseparation betweenthesetwo populations(Fig.1B).Thestudy ofThelper subtypesperformedwithindLNhighlightstheCD4+ Tcell plas-ticity,andthecloserelationshipbetweendifferentThcelllineages [38,39].
3.3. Thelpersubpopulationsinspleenandlungs
Atthesametimepoint,theprofileofprimedTet+Tcellswas analysedintospleenandlungs.ThesubpopulationsdetectedindLN wereobservedalsointhespleenbutwithdifferentfrequencies (Fig.2A).Tfhcells(PD-1+CXCR5+expressingBcl-6)wereabout8% ofTet+Tcells,whilethefrequencyofCXCR3+T-bet+Th1cellswas around42%(Fig.2A,panelsb,d,e).About40%expressedROR␥t (Fig.2A,panelf),ofthesecells,20%co-expressedT-bet,whileabout 78%werepositiveonlyforROR␥tandonly2%co-expressedROR␥t andBcl-6(Fig.2A,panelg).
Theanalysisperformedinthelungsshowedtheabsenceofboth Tfh(CXCR5+PD-1+)andTh1(CXCR5−PD-1−CXCR3+)cells(Fig.2B, panelsbandc).About30%ofTet+TcellsexpressedROR␥t,and mostofthem(81%)didnotco-expressedothertranscriptionfactors (Fig.2B,panelsdande).ThesedatashowaprevalenceofTh1cells inthespleenandROR␥t-positivecellsinlungs.
3.4. EffectofboosterimmunizationonAg85B-specificCD4+Tcells Theresponse ofprimedAg85B-specificCD4+ Tcells andthe persistenceofThsubpopulationswerestudieduponbooster immu-nizationwith H56and CAF01 in dLN,spleen and lungs 7 days afterboosting. Asignificantincreaseinthepercentage ofTet+T cellswasobservedinallinvestigatedorgansindicativeoftherecall response,andthefrequenciesofTet+Tcellsincreasedto0.56%,1% and2.3%indLN,spleenandlungs,respectively(P<0.001,P<0.01 andP<0.05respecttoprimedgroups;Fig.3A).TheamountofTet+T cellsafterboosterimmunizationwasabout40,000±8,000cellsin dLN,42,000±10,000inlungs,and183,000±54,000inthespleens (meanvalue±SEMof15mice),andthefold-increaserespecttothe amountgeneratedbytheprimaryimmunizationwas7.2,4.2and 2.6inlungs,spleenanddLN,respectively(datanotshown).CD127 expression,thatisbelievedtobeindicativeofmemory,was ana-lysedinTet+T-cells.Afterboosterimmunizationthefrequencyof Tet+CD44hiCD127+antigen-experiencedTcellsincreasedrespect toprimedcells (Fig.3B).Thefrequency,aswellastheabsolute number,ofPD-1+CXCR5+Tfhcellsdetecteduponpriming, signifi-cantlydecreasedfollowingboosterimmunizationbothindLNand spleens(Fig.4A),whilethepercentageofTh1andTh17cellswere steadilymaintainedinallorgans(Fig.4A).Theanalysisoffunctional activityofTcellscollectedfromdLNcorrelatedwiththephenotype observed,asshownbytheproductionofIFN-␥andIL-17,while
Fig.3. FrequencyofAg85B-specificCD4+Tcellsfollowingboosterimmunization.C57BL/6micewereprimedwithH56andCAF01andboosted4weekslater.Lymphocytes
fromdLN,SPLandlungs,collected7daysafterprimaryorboosterimmunization,werestainedwithAg85B280–294MHCclassIItetramersandsurfacemarkerantibodies.
(A)FrequenciesofTet+TcellsrespecttoCD4+cellsfollowingprimary(gray)orboosterimmunization(black).Dataarereportedasthemean±SEMof15micefromthree
independentexperiments.Two-tailedStudent’st-testwasusedforcomparingvalues.*P<0.05,**P<0.01,and***P<0.001.(B)CD44versusCD127expressiononCD4+
tetramer-Ag85B+gatedcellsfollowingprimary(left)orbooster(right)immunizationindLN(toppanels),spleen(middlepanels)andlungs(bottompanels).Percentagesof
CD44andCD127doublepositivecellsrespecttoCD4+tetramer-Ag85B+cellsareshown.Dotplotsrepresentasingleanimalfrom2independentexperimentswith5mice
each;about106cellswerestoredforeachsample.
thereleaseofIL-2wasindicativeoftheproliferativeresponseand activationprogramofTet+Tcells(Fig.4B).
4. Discussion
Thepresentworkexplorestheantigen-specificCD4+T prolifera-tionanddifferentiationintoThelpersuptypesfollowingparenteral immunizationwiththevaccineformulationH56andCAF01.Our datahighlightthatthepeptide-specificpopulation,identifiedby MHCclassIItetramers,produceddifferenteffectorcellpatterns upon antigen encounter, and that thefrequency of subpopula-tionsdiffered according to theirlocalization. In particular, Tfh, Th1and ROR␥t+ cells wereall inducedinto dLNtogether with “transitional”subtypes thatco-expressedmultiple helperTcell lineage-specifyingtranscriptionfactors.Tfhcellswerelargely har-bouredwithinLNdrainingtheimmunizationsite,whileTh1cells werepredominantinthespleen,andROR␥t+ cellsin thelungs. Therefore,ourresultsshowthatprimedThelpercellsthat recog-nizedthesamepeptide-MCHclassIIcomplex,didnotdifferentiate into a single polarized phenotype but in more subtypes, that
showedadifferentfateuponreactivation.Althoughthecytokine milieuit isknowntoplayanimportantroleindeterminingthe typesofeffectorcellsgenerated,recentevidencehasdemonstrated thatsignalsreceivedthroughtheTCRarealsoimportantforeffector celldifferentiation[26].Theinterclonalandintraclonalfunctional heterogeneityofCD4+Tcellsprimedbypathogensorvaccineshas alsobeenrecentlydemonstratedbyTCRdeepsequencing[40],thus supportingtheone-cellmultiplefatesmodelofhelperTcells dif-ferentiation.TheCD4+T-cellresponsethatwehavetrackedusing Ag85Bepitope-specifictetramers,canbeconsidered representa-tiveoftheresponsetowardsthewholevaccine,sinceithasbeen previouslyshowntobeanimmunodominantpeptide[32]andthe stainingwithtetramersspecificforotherepitopesincludedinH56, didnotidentifyanypopulation.
GenerationofTfhcellsisessentialfortheefficacyofvaccinesin whichantibodyresponseisstronglyrequired.Ag85B-specificTfh cellsweredetecteduponprimingwithindLN,andwithalower frequencyinthespleen.WhetherTfhcellsestablishapersistent localmemorycompartmentisstillpoorlyunderstood,asitisnot clearifTfhareterminallydifferentiatedcells orcangiveriseto
6828 G.Protaetal./Vaccine33(2015)6823–6830
B
IL-2 IFNγ IL-17 IL-4 IL-10 IL-21
0
10
20
30
40
50
60
boosted
naive
primed
70
170
270
370
470
570
pg/ml
primed boosted 0 10 20 30 40 50 60 primed boosted 0 10 20 30 40 50 60 primed boosted 0 10 20 30 40 50 60 primed boosted 0 10 20 30 40 50 60***
***
Tfh (%) Th1 (%)dLN
SPL
A
primed boosted 0 10 20 30 40 50 60 primed boosted 0 10 20 30 40 50 60 primed boosted 0 10 20 30 40 50 60LUNGS
primed boosted 0 10 20 30 40 50 60 primed boosted 0 10 20 30 40 50 60 Th17 (%)Fig.4. Ag85B-specificCD4+Tcellsuponboosterimmunization.GroupsofC57BL/6micewereprimedwithH56andCAF01andboosted4weekslater.Lymphocytesfrom
dLN,SPLandlungswerecollected7daysafterprimaryorboosterimmunizationandstainedwithAg85B280–294MHCclassIItetramers,surfaceandintracellularantibodies.
A.FrequenciesofTfh(CXCR5+PD-1+),Th1(CXCR5−PD-1−CXCR3+),andTh17(Bcl-6−T-bet−ROR␥t+)cellsrespecttoTet+TcellsindLN,SPLandlungsfollowingprimary
(gray)orbooster(black)immunization.Barsrepresentthemeanfrequencies±SEMof10micefromtwoindependentexperiments.Frequenciesofdifferentsubpopulations werecomparedusingthetwo-tailedStudent’st-test.*P<0.05,**P<0.01,and***P<0.001.(B)IL-2,IFN␥,IL-17,IL-4,IL-10andIL-21concentrationsassessedbyBio-Plex immunoassayinculturesupernatantsoflymphocytesrestimulatedwithH56for72h,collectedfromdLNofnaive(white),primed(dotted)orboosted(gray)mice.
otherhelperTcellsubsets oncethegerminalcenter reactionis resolved[41].Ourdatashowthepresenceofantigen-experienced CD44highCD127+Tet+TcellswithindLNafterbooster immuniza-tion,neverthelessweobserved a reduction ofCXCR5 and PD-1 double-positivecells,whileCXCR3+Th1cellsweresteadily main-tained.RecentstudiesshowthatTfhcellsgiverisetomemoryT cellswithunexpectedplasticitythatallowthemtore-differentiate alsointoconventionalhelperTcells[41].Thissupportstheideathat
Tfhcellsarenotterminallydifferentiated,andmaintainaclose rela-tionshipwithotherThcelllineages.Thedevelopmentalplasticity modelofThdifferentiationisalsosupportedbythetranscription factorsanalysisthatweperformedamongTet+Tcellsafter prim-ing.Theanalysisclearlyshowednotonlythepresenceof“defined” Thsubpopulations,suchasTfhand Th1,butalsooftransitional phenotypes,inwhichtheco-expressionofmorethanone“master” transcriptionfactorwasobserved.WedetectedCXCR5+PD-1+cells
thatexpressedBcl-6togetherwithROR␥t,orCXCR5−PD-1−CXCR3+ cellspositiveforbothROR␥tandT-bet.Whiletheco-expression ofROR␥tandT-bethasbeenfrequentlyreported[39],more stri-kinglyistheexpressionofROR␥twithinCXCR5+PD-1+Bcl-6+cells. In general,thereis a highdegreeof uncertainty asto whether Th17cellsrepresentastable,terminallydifferentiatedThlineage. Somestudieshave highlightedthat Th17cellscanprovidehelp toBcellsandpromoteGCformationincludingisotypeswitching [42],orthatintestinalTh17cellsacquiredaTfhphenotypewithin Peyer’s patchesand inducedthedevelopmentof IgA-producing germinalcenterBcells[43].Takentogether,thesedatasuggestthat theconcomitantexpressionofROR␥tandBcl-6lineage-specifying transcriptionfactorscanbeduetoatransientstatusofcellsthat wereredirectingtheirphenotypeandfunctiontowardsonespecific subtype,inaccordancewithaplastic,morethandefined,modelof Tcelldifferentiation[39].
Following parenteral immunization, primed and boosted Ag85B-specificCD4+Tcellsweredetectedalsointhelungs.We canspeculatethatmostofreactivatedcellsexitthedLNto dissem-inateintolungs,butalsothatlungtissue-residentmemorycells, generatedbyprimaryimmunization,werereactivatedinsituby boosterimmunization.Ithasbeendemonstratedthatitis tech-nicallycomplextodistinguishparenchyma-associatedfromlung bloodvasculaturecirculatingcells[44];thereforewearecurrently workingfor characterizingthe actuallocalization ofthese cells (unpublisheddata).ThephenotypicanalysisofTet+Tcells asso-ciatedwiththelungsshowedcharacteristicsdifferentfromcells detectedinthelymphoidcompartments,asshownbytheabsence ofTfhandTh1cells.SinceCXCR3affectstraffickingofeffectorT cellstothelungsuponintranasalinfection[45,46],thelow expres-sionofCXCR3onTet+Tcellscouldmeanthatcellswerealready residentinthelungs.Nevertheless,itisalsopossiblethatother chemokinescanmediateTet+Tcellsmigrationtothelungs, follow-ingaparenteralimmunization.Interestingly,Ag85B-specificCD4+ TcellsdetectedinthelungsexpressedprevalentlyROR␥tassingle mastertranscriptionfactorinlinewithpre-clinicaldataobtained withCAF01adjuvantthatobservedtheinductionofTh17cells[29]. Th17cellsplayanimportantroleinprotectiveimmunityagainst severalpathogens,andinsuchcasesitwouldbehighlyrelevant andbeneficialtoinduceTh17responses.
Inconclusion,ourresultsshowthatThelpercellsthatrecognize thesamepeptide-MCHclassIIcomplexdifferentiateintomore sub-sets,withdifferentfrequenciesaccordingtotheirlocalization.Tfh cellswereelicitedandharbouredwithinLNdrainingthe immuniza-tionsite,whileTh1werepredominantinthespleen,andROR␥t+ cellsinthelungs.Thelpercellsalsodisplayedahighdegreeof plas-ticity,asshownbyboththepresenceof“transitional”subtypesthat co-expressedmultiple“masterregulator”factors,andphenotypes ofreactivatedmemorycellsthatwerepartiallydifferentfromthose observeduponpriming.Thesedataproviderelevantknowledge aboutCD4+ Tcellresponseselicitedbythevaccineformulation H56andCAF01andontheroleoftheprimingeventinaffecting thecellularresponseinthecontextofavaccinationstrategy.
Acknowledgments
TheauthorsacknowledgetheNIHTetramerCoreFacility (con-tractHHSN272201300006C)forprovisionofMHCclassIItetramers, andtheNovartisVaccineFlowCytometryFacilityforassistanceand advices.TheauthorsthankAnnaMariaCupponeandFabioFiorino fortheirexcellenttechnicalassistance.
Thisstudyhasbeencarriedoutwithfinancialsupportfromthe CommissionoftheEuropeanCommunities,Seventh Framework Programme, contract HEALTH-2011-280873 “Advanced Immu-nizationTechnologies”(ADITEC).
References
[1]SiegristCA.Vaccineimmunology.In:PlotkinAA,OrensteinWA,OffitPA, edit-ors.Vaccines.Philadelphia:ElsevierInc.;2008.p.17–36.
[2]CiabattiniA,PettiniE,MedagliniD.CD4(+)Tcellprimingasbiomarkertostudy immuneresponsetopreventivevaccines.FrontImmunol2013;4:421. [3]HusterKM,BuschV,SchiemannM,LinkemannK,KerksiekKM,WagnerH,etal.
SelectiveexpressionofIL-7receptoronmemoryTcellsidentifiesearly CD40L-dependentgenerationofdistinctCD8+memoryTcellsubsets.ProcNatlAcad SciUSA2004;101(15):5610–5.
[4]WoodlandDL.Jump-startingtheimmunesystem:prime-boostingcomesof age.TrendsImmunol2004;25(2):98–104.
[5]FiorinoF,PettiniE,PozziG,MedagliniD,CiabattiniA.Prime-booststrategiesin mucosalimmunizationaffectlocalIgAproductionandthetypeofThresponse. FrontImmunol2013;4:128.
[6]GalliG,MediniD,GorgogniE,ZeddaL,BardelliM,MalzoneC,etal. Adju-vanted H5N1 vaccine induces early CD4+ T cell response thatpredicts long-termpersistenceofprotectiveantibodylevels.ProcNatlAcadSciUSA 2009;106(10):3877–82.
[7]NayakJL,FitzgeralsTF,RichardsKA,YangH,TreanorJJ,SantAJ.CD4+T-cell expansionpredictsneutralizingantibodyresponsestomonovalent,inactivated 2009pandemicinfluenzaA(H1N1)virussubtypeH1N1vaccine.JInfectDis 2013;207(2):297–305.
[8]McKeeAS,BurchillMA,MunksMW,JinL,KapplerJW,FriedmanRS,etal. HostDNAreleasedinresponsetoaluminumadjuvantenhancesMHCclass II-mediatedantigenpresentationandprolongsCD4T-cellinteractionswith dendriticcells.ProcNatlAcadSciUSA2013;110(12):E1122–31.
[9]CiabattiniA,PettiniE,FiorinoF,ProtaG,PozziG,MedagliniD.Distributionof primedTcellsandantigen-loadedantigenpresentingcellsfollowingintranasal immunizationinmice.PLoSONE2011;6(4):e19346.
[10]McAleerJP,VellaAT.EducatingCD4Tcellswithvaccineadjuvants:lessons fromlipopolysaccharide.TrendsImmunol2010;31(11):429–35.
[11]MarksEM,HelgebyA,AnderssonJO,SchönK,LyckeNY.CD4+T-cellimmunityin thefemalegenitaltractiscriticallydependentonlocalmucosalimmunization. EurJImmunol2011;41(9):2642–53.
[12]PettiniE,CiabattiniA,PozziG,MedagliniD.AdoptivetransferoftransgenicT cellstostudymucosaladjuvants.Methods2009;49(4):340–5.
[13]Jelley-GibbsDM,StruttTM,McKinstryKK,SwainSL.Influencingthefatesof CD4Tcellsonthepathtomemory:lessonsfrominfluenza.ImmunolCellBiol 2008;86(4):343–52.
[14]LanzavecchiaA,SallustoF.Understandingthegenerationandfunctionof mem-oryTcellsubsets.CurrOpinImmunol2005;17(3):326–32.
[15]TuboNJ,JenkinsMK.TCRsignalquantityandqualityinCD4Tcell differentia-tion.TrendsImmunol2014;35(12):591–6.
[16]CrottyS.Follicular helper CD4 Tcells (TFH). AnnuRev Immunol 2011; 29:621–63.
[17]HaynesNM,AllenCD,LesleyR,AnselKM,KilleenN,CysterJG.RoleofCXCR5 andCCR7infollicularThcellpositioningandappearanceofaprogrammed celldeathgene-1highgerminalcenter-associatedsubpopulation.JImmunol 2007;179(8):5099–108.
[18]BacherP,ScheffoldA.Flow-cytometricanalysisofrareantigen-specificTcells. CytometryA2013;83(8):692–701.
[19]KearneyER,PapeKA,LohDY,JenkinsMK.Visualizationofpeptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity 1994;1(4):327–39.
[20]CiabattiniA,PettiniE,AndersenP,PozziG,MedagliniD.Primaryactivationof antigen-specificnaiveCD4+andCD8+Tcellsfollowingintranasalvaccination withrecombinantbacteria.InfectImmun2008;76(12):5817–25.
[21]MedagliniD,CiabattiniA,CupponeAM,CostaC,RicciS,CostalongaM,etal. InvivoactivationofnaiveCD4+Tcellsinnasalmucosa-associatedlymphoid tissuefollowingintranasalimmunizationwithrecombinantStreptococcus gor-donii.InfectImmun2006;74(5):2760–6.
[22]PettiniE,ProtaG,CiabattiniA,BoianelliA,FiorinoF,PozziG,etal.Vaginal immunizationtoelicitprimaryT-cellactivationanddissemination.PLoSONE 2013;8(12):e80545.
[23]McHeyezer-WilliamsMG,AltmanJD,DavisMM.Enumerationand charac-terizationofmemorycellsintheTHcompartment.ImmunolRev1996;150: 5–21.
[24]CrawfordF,KozonoH,WhiteJ,MarrackP,KapplerJ.Detectionof antigen-specific T cells with multivalent soluble class II MHC covalent peptide complexes.Immunity1998;8(6):675–82.
[25]PepperM,PaganAJ,IgyartoBZ,TaylorJJ,JenkinsMK.Opposingsignalsfrom theBcl6transcriptionfactorandtheinterleukin-2receptorgenerateThelper 1centralandeffectormemorycells.Immunity2011;35(4):583–95. [26]TuboNJ,PaganAJ,TaylorJJ,NelsonRW,LinehanJL,ErteltJM,etal.Singlenaive
CD4+Tcellsfromadiverserepertoireproducedifferenteffectorcelltypes duringinfection.Cell2013;153(4):785–96.
[27]AagaardC,HoangT,DietrichJ,CardonaPJ,IzzoA,DolganovG,etal.Amultistage tuberculosisvaccinethatconfersefficientprotectionbeforeandafterexposure. NatMed2011;17(2):189–94.
[28]LindenstromT,AggerEM,Korsholm KS,DarrahPA,Aagaard C,SederRA, etal.Tuberculosissubunitvaccinationprovideslong-termprotective immu-nity characterized by multifunctional CD4 memory T cells. J Immunol 2009;182(12):8047–55.
[29]Lindenstrom T, Woodworth J, Dietrich J, Aagaard C, Andersen P, Agger EM.Vaccine-inducedTh17cellsaremaintainedlong-termpostvaccination
6830 G.Protaetal./Vaccine33(2015)6823–6830 as a distinct and phenotypically stable memory subset. Infect Immun
2012;80(10):3533–44.
[30]Agger EM, RosenkrandsI, Hansen J, Brahimi K,Vandahl BS,Aagaard C, etal.Cationicliposomesformulatedwithsyntheticmycobacterial cordfac-tor(CAF01):aversatileadjuvantforvaccineswithdifferentimmunological requirements.PLoSONE2008;3(9):e3116.
[31]vanDisselJT,JoostenSA,HoffST,SoonawalaD,PrinsC,HokeyDA,etal.A novelliposomaladjuvantsystemCAF01,promoteslong-livedMycobacterium tuberculosis-specificT-cellresponsesinhuman.Vaccine2014;32:7098–107. [32]BennekovT,DietrichJ,RosenkrandsI,StryhnA,DohertyTM,AndersenP.
Alter-ationofepitoperecognitionpatterninAg85BandESAT-6hasaprofound influenceonvaccine-inducedprotectionagainstMycobacteriumtuberculosis. EurJImmunol2006;36(12):3346–55.
[33]Nurieva RI, Chung Y, Martinez GJ, Yang XO, TanakaS, Matskevitch TD, etal. Bcl6mediatesthedevelopmentof Tfollicularhelper cells.Science 2009;325(5943):1001–5.
[34]SzaboSJ,KimST,CostaGL,Zhang X,FathmanCG,GlimcherLH.Anovel transcription factor T-bet, directs Th1 lineage commitment. Cell 2000; 100(6):655–69.
[35]IvanovII,McKenzieBS,ZhouL,TadokoroCE,LepelleyA,LafailleJJ,etal.The orphannuclearreceptorRORgammatdirectsthedifferentiationprogramof proinflammatoryIL-17+Thelpercells.Cell2006;126(6):1121–33.
[36]GroomJR,LusterAD.CXCR3inTcellfunction.ExpCellRes2011;317:620–31. [37]BentebibelSE,LopezS,ObermoserG,SchmittN,MuellerC,HarrodC,etal. InductionofICOS+CXCR3+CXCR5+THcellscorrelateswithantibodyresponses toinfluenzavaccination.SciTranslMed2013;5(176):176ra32.
[38]EvansCM,JennerRG.TranscriptionfactorinterplayinThelpercell differenti-ation.BriefFunctGenomics2013;12(6):499–511.
[39]Oestreich KJ, Weinmann AS. Master regulators or lineage-specifying? Changing views on CD4+ Tcell transcription factors. Nat Rev Immunol 2012;12(11):799–804.
[40]BecattiniS,LatorreD,MeleF,FoglieriniM,DeGregorioC,CassottaA,etal.T cellimmunity.FunctionalheterogeneityofhumanmemoryCD4+Tcellclones primedbypathogensorvaccines.Science2015;347(6220):400–6.
[41]LuthjeK,KalliesA,ShimohakamadaY,BelzGT,LightA,TarlintonDM,etal.The developmentandfateoffollicularhelperTcellsdefinedbyanIL-21reporter mouse.NatImmunol2012;13(5):491–8.
[42]MitsdoerfferM,LeeY,JagerA,KimHJ,KornT,KollsJK,etal.Proinflammatory Thelpertype17cellsareeffectiveB-cellhelpers.ProcNatlAcadSciUSA 2010;107(32):14292–7.
[43]HirotaK,TurnerJE,VillaM,DuarteJH,DemengeotJ,SteinmetzOM,etal. PlasticityofTh17cellsinPeyer’spatchesisresponsiblefortheinductionof Tcell-dependentIgAresponses.NatImmunol2013;14(4):372–9.
[44]AndersonKG,SungH,SkonCN,LefrancoisL,DeisingerA,VezysV,etal.Cutting edge:intravascularstainingredefineslungCD8Tcellresponses.JImmunol 2012;189(6):2702–6.
[45]KohlmeierJE,CookenhamT,MillerSC,RobertsAD,ChristensenJP,Thomsen AR,etal.CXCR3directsantigen-specificeffectorCD4+Tcellmigrationtothe lungduringparainfluenzavirusinfection.JImmunol2009;183(7):4378–84. [46]SakaiS,KauffmanKD,SchenkelJM,McBerryCC,Mayer-BarberKD,MasopustD,
etal.Cuttingedge:controlofMycobacteriumtuberculosisinfectionbyasubset oflungparenchyma-homingCD4Tcells.JImmunol2014;192(7):2965–9.